Organogenesis Holdings (ORGO) Interest Expenses (2016 - 2026)

Organogenesis Holdings' Interest Expenses history runs 11 years deep, the most recent figure standing at -$380000.0 for Q1 2026.

• On a quarterly basis, Interest Expenses fell 103.01% year-over-year to -$380000.0 in Q1 2026; TTM through Mar 2026 was -$7.5 million, a 159.3% decrease from a year earlier, with the FY2025 full-year figure at $20.0 million, up 33.49% from the prior year.
• Interest Expenses retreated to -$380000.0 in Q1 2026 per ORGO's latest filing, from -$236000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $66.1 million in Q2 2022 and bottomed at -$4.3 million in Q4 2022.
• The 5-year median for Interest Expenses is $5.5 million (2025), against an average of $17.9 million.
• Across the five-year window, Interest Expenses slumped 406.9% in 2022 and surged 298.12% in 2023, its largest moves.
• Year by year, Interest Expenses stood at -$4.3 million in 2022, then surged by 165.75% to $2.8 million in 2023, then slumped by 190.27% to -$2.6 million in 2024, then surged by 90.78% to -$236000.0 in 2025, then slumped by 61.02% to -$380000.0 in 2026.
• Per Business Quant, the three latest ORGO Interest Expenses figures stand at -$380000.0 (Q1 2026), -$236000.0 (Q4 2025), and $10.8 million (Q3 2025).